Litcius/Paper detail

Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective

David Halpin, Dave Singh, Ruth M. Hadfield

2020European Respiratory Journal325 citationsDOIOpen Access PDF

Abstract

<b>There is no evidence on benefits or harms of inhaled steroids in COVID-19. It is essential that epidemiological studies of COVID-19 include detailed information on comorbidities and prior medication to help answer this question.</b>https://bit.ly/2XVwIsa

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)Inhaled corticosteroidsSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Perspective (graphical)2019-20 coronavirus outbreakEpidemiologyIntensive care medicineSystematic reviewAdrenal cortex hormonesMEDLINEVirologyImmunologyInternal medicineAsthmaOutbreakArtificial intelligenceInfectious disease (medical specialty)DiseasePolitical scienceComputer scienceLawInhalation and Respiratory Drug DeliveryAsthma and respiratory diseasesRespiratory Support and Mechanisms
Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective | Litcius